BioStem Technologies, Inc. (BSEM) vs DarioHealth Corp. (DRIO)
A side-by-side comparison of BioStem Technologies, Inc. and DarioHealth Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.55HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
DRIO
DarioHealth Corp.
$6.05HealthcareDelayed quote: Oct 6, 2026, 2:07 PM EDT
Total return — BSEM vs DRIO
growth of $100 · dividends reinvested · last 10yBSEM -72.4% (-12.1%/yr)DRIO -99.6% (-42.1%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
BSEM DRIO
BSEM vs DRIO: by the numbers
- •DRIO is the larger company ($44M vs $43M market cap).
- •DRIO is profitable (322.77% net margin) while BSEM runs a net loss (-13.86%).
Metrics side by side
Valuation
| Metric | BSEM | DRIO |
|---|---|---|
| P/E ratio | N/A | 8.77 |
| P/S ratio | N/A | 2.11 |
| P/B ratio | 1.57 | 0.80 |
Profitability
| Metric | BSEM | DRIO |
|---|---|---|
| Gross margin | 93.13% | 56.09% |
| Operating margin | -1.45% | -163.94% |
| Net margin | -13.86% | 322.77% |
| ROE | -102.45% | 123.04% |
| ROIC | -80.92% | -78.42% |
Growth (annualized)
| Metric | BSEM | DRIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.10% |
| Total return CAGR (5Y) | 15.72% | -52.92% |
Frequently asked
- Is BSEM or DRIO more profitable?
- DRIO runs the higher net margin — BSEM at -13.86% versus DRIO at 322.77%.
- How have BSEM and DRIO total returns compared?
- Over the past 10 years, BSEM delivered -12.08% and DRIO delivered -42.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DarioHealth P/E ratioBioStem Technologies ROEDarioHealth ROEBioStem Technologies operating marginDarioHealth operating marginBioStem Technologies revenue growthDarioHealth revenue growthBioStem Technologies free cash flowDarioHealth free cash flow
BioStem Technologies & DarioHealth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.